Perkins Capital Management Inc Atri Cure, Inc. Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 29,950 shares of ATRC stock, worth $905,987. This represents 0.83% of its overall portfolio holdings.

Number of Shares

29,950

Previous 30,450 1.64%

Holding current value

$905,987

Previous $693,000 21.07%

% of portfolio

0.83%

Previous 0.68%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$20.34 - $29.5 $10,170 - $14,750	-500 Reduced 1.64%	29,950 $839,000
Q2 2024 Aug 09, 2024	BUY	$19.86 - $29.09 $51,636 - $75,634	2,600 Added 9.34%	30,450 $693,000
Q4 2023 Jan 22, 2024	SELL	$32.99 - $43.25 $49,485 - $64,875	-1,500 Reduced 5.11%	27,850 $994,000
Q3 2023 Nov 02, 2023	SELL	$41.12 - $57.73 $41,120 - $57,730	-1,000 Reduced 3.29%	29,350 $1.29 Million
Q2 2023 Jul 21, 2023	SELL	$40.44 - $49.6 $121,320 - $148,800	-3,000 Reduced 9.0%	30,350 $1.5 Million
Q4 2022 Jan 26, 2023	SELL	$33.48 - $47.45 $33,480 - $47,450	-1,000 Reduced 2.91%	33,350 $1.48 Million
Q1 2022 Apr 20, 2022	SELL	$57.43 - $71.39 $229,720 - $285,560	-4,000 Reduced 10.43%	34,350 $2.26 Million
Q1 2021 Apr 28, 2021	SELL	$53.79 - $66.98 $147,922 - $184,195	-2,750 Reduced 6.69%	38,350 $2.51 Million
Q4 2020 Feb 09, 2021	SELL	$34.56 - $57.55 $112,320 - $187,037	-3,250 Reduced 7.33%	41,100 $2.29 Million
Q3 2020 Oct 28, 2020	SELL	$38.36 - $46.91 $245,504 - $300,224	-6,400 Reduced 12.61%	44,350 $1.77 Million
Q1 2020 Apr 29, 2020	BUY	$24.49 - $43.84 $50,204 - $89,872	2,050 Added 4.21%	50,750 $1.71 Million
Q4 2019 Feb 03, 2020	SELL	$24.06 - $32.51 $151,578 - $204,813	-6,300 Reduced 11.45%	48,700 $1.58 Million
Q3 2019 Oct 23, 2019	SELL	$23.81 - $32.52 $136,907 - $186,990	-5,750 Reduced 9.47%	55,000 $1.37 Million
Q2 2019 Aug 09, 2019	SELL	$26.85 - $30.74 $134,250 - $153,700	-5,000 Reduced 7.6%	60,750 $1.81 Million
Q1 2019 Apr 22, 2019	SELL	$26.38 - $33.34 $263,800 - $333,400	-10,000 Reduced 13.2%	65,750 $1.76 Million
Q4 2018 Feb 11, 2019	SELL	$26.66 - $34.85 $13,330 - $17,425	-500 Reduced 0.66%	75,750 $2.32 Million
Q3 2018 Oct 22, 2018	BUY	$27.62 - $35.58 $138,100 - $177,900	5,000 Added 7.02%	76,250 $2.67 Million
Q2 2018 Aug 02, 2018	SELL	$19.65 - $30.28 $9,825 - $15,140	-500 Reduced 0.7%	71,250 $1.93 Million
Q1 2018 Apr 23, 2018	SELL	$15.05 - $21.03 $252,840 - $353,304	-16,800 Reduced 18.97%	71,750 $1.47 Million
Q4 2017 Jan 26, 2018	SELL	$17.69 - $23.44 $77,836 - $103,136	-4,400 Reduced 4.73%	88,550 $1.62 Million
Q3 2017 Oct 31, 2017	BUY	$20.0 - $24.23 $1.86 Million - $2.25 Million	92,950	92,950 $2.08 Million

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.4B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Atri Cure, Inc. Transaction History